Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02457910
Title Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama, Birmingham Birmingham Alabama 35249 United States Details
Georgetown University Washington District of Columbia 20007 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana University Indianapolis Indiana 47405 United States Details
John Hopkins University Baltimore Maryland 21218 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Michigan Ann Arbor Michigan United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15260 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Baylor Breast Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field